Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBankers Investment Trust Regulatory News (BNKR)

Share Price Information for Bankers Investment Trust (BNKR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.80
Bid: 112.20
Ask: 112.80
Change: 0.40 (0.36%)
Spread: 0.60 (0.535%)
Open: 111.00
High: 113.00
Low: 111.00
Prev. Close: 112.40
BNKR Live PriceLast checked at -
Bankers Investment Trust is an Investment Trust

aims to achieve capital and dividend growth over the long term

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on The Bankers Invst Trust

14 Aug 2023 07:15

RNS Number : 1150J
Bankers Investment Trust PLC
14 August 2023
 

London, UK, 14 August 2023

 

Edison issues review on The Bankers Investment Trust (BNKR)

The Bankers Investment Trust (BNKR) posted an 8.1% net asset value (NAV) per share total return (TR) in H123 (period ending 30 April 2023). Most of its regional sub-portfolios (sleeves) outperformed their benchmarks, highlighting the respective managers' strong stock-selection capabilities. Dividend income across the portfolio was up 10% in H123 and BNKR declared a second interim dividend of 0.62p (with the ytd payout up c 10% y-o-y). Moreover, Alex Crooke (BNKR's lead manager) now expects FY23 dividend growth of at least 7% versus 5% earlier, which he believes should allow BNKR (after high inflation in FY22) to resume its track record of delivering dividend growth ahead of UK inflation.

 

BNKR can be viewed as a 'one-stop shop' for global equity exposure. Its portfolio consists of six geographic sleeves, managed by Janus Henderson Investors' (JHI's) regional specialists. It is an interesting proposition for investors seeking a global equities portfolio that is balanced geographically, large-cap biased and style-neutral, providing both exposure to growth stocks and growing income. We note that Crooke has recently increased the trust's exposure to more defensive businesses, while avoiding the most popular technology stocks. The manager acknowledges the ongoing disruption caused by the implementation of AI, but focuses on more diverse companies that should benefit from the trend, such as Microsoft and Accenture, rather than pure-play AI businesses.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 Michal Mordel +44 (0)20 3077 5700

investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFLFFXVLZBBL
Date   Source Headline
18th May 202312:45 pmRNSNet Asset Value(s)
17th May 202312:57 pmRNSNet Asset Value(s)
16th May 20231:15 pmRNSNet Asset Value(s)
15th May 20233:00 pmRNSNet Asset Value(s)
12th May 20231:29 pmRNSNet Asset Value(s)
11th May 202312:53 pmRNSNet Asset Value(s)
10th May 202312:55 pmRNSNet Asset Value(s)
9th May 20232:34 pmRNSNet Asset Value(s)
5th May 202312:46 pmRNSNet Asset Value(s)
4th May 20234:19 pmRNSPortfolio Update
4th May 202311:44 amRNSNet Asset Value(s)
3rd May 202311:44 amRNSNet Asset Value(s)
2nd May 20233:56 pmRNSNet Asset Value(s)
2nd May 20239:35 amRNSTotal Voting Rights
28th Apr 202312:47 pmRNSNet Asset Value(s)
27th Apr 202311:23 amRNSNet Asset Value(s)
26th Apr 20235:10 pmRNSTransaction in Own Shares
26th Apr 20232:08 pmRNSMonthly Factsheet as at 31 March 2023
26th Apr 202311:29 amRNSNet Asset Value(s)
25th Apr 202312:03 pmRNSNet Asset Value(s)
24th Apr 20232:49 pmRNSNet Asset Value(s)
21st Apr 20235:14 pmRNSTransaction in Own Shares
21st Apr 202311:13 amRNSNet Asset Value(s)
20th Apr 20235:12 pmRNSTransaction in Own Shares
20th Apr 202311:57 amRNSNet Asset Value(s)
19th Apr 20235:11 pmRNSTransaction in Own Shares
19th Apr 202312:00 pmRNSNet Asset Value(s)
18th Apr 20235:16 pmRNSTransaction in Own Shares
18th Apr 202312:47 pmRNSNet Asset Value(s)
17th Apr 20235:13 pmRNSTransaction in Own Shares
17th Apr 20231:43 pmRNSNet Asset Value(s)
14th Apr 202311:58 amRNSNet Asset Value(s)
13th Apr 20235:23 pmRNSTransaction in Own Shares
13th Apr 202312:51 pmRNSNet Asset Value(s)
12th Apr 20235:14 pmRNSTransaction in Own Shares
12th Apr 202311:51 amRNSNet Asset Value(s)
11th Apr 20235:11 pmRNSTransaction in Own Shares
11th Apr 20232:25 pmRNSNet Asset Value(s)
6th Apr 20235:07 pmRNSTransaction in Own Shares
6th Apr 20231:04 pmRNSNet Asset Value(s)
5th Apr 20235:11 pmRNSTransaction in Own Shares
5th Apr 202312:34 pmRNSNet Asset Value(s)
4th Apr 20235:10 pmRNSTransaction in Own Shares
4th Apr 202312:47 pmRNSNet Asset Value(s)
3rd Apr 20235:22 pmRNSTransaction in Own Shares
3rd Apr 20234:22 pmRNSNet Asset Value(s)
3rd Apr 20239:21 amRNSTotal Voting Rights
31st Mar 202312:48 pmRNSNet Asset Value(s)
30th Mar 20235:12 pmRNSTransaction in Own Shares
30th Mar 202312:11 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.